These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12925158)

  • 1. Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity.
    Thorpe SJ; Fox BJ; Dolman CD; Lawrence J; Thorpe R
    Vox Sang; 2003 Aug; 85(2):80-4. PubMed ID: 12925158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Rh D activity of commercial intravenous immunoglobulin preparations.
    Turner CE; Thorpe SJ; Brasher MD; Thorpe R
    Vox Sang; 1999; 76(1):55-8. PubMed ID: 9933855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin products.
    Thorpe SJ; Fox B; Heath A; Dolman C; Virata ML; Yu MW; Thorpe R
    Vox Sang; 2005 May; 88(4):278-87. PubMed ID: 15877651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method.
    Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products.
    Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
    Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States.
    Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MY
    Biologicals; 2006 Sep; 34(3):209-12. PubMed ID: 16492398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
    Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
    Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: are they on the rise? A comparison of four different analysis methods and six products.
    Bellac CL; Polatti D; Hottiger T; Girard P; Sänger M; Gilgen M
    Biologicals; 2014 Jan; 42(1):57-64. PubMed ID: 24325871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
    Thorpe SJ
    Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International collaborative study to assess new stocks of candidate reference preparations to control the level of anti-D in IVIG.
    Thorpe SJ; Virata ML; Fox B; Terao E
    Pharmeur Bio Sci Notes; 2024; 2024():76-89. PubMed ID: 38949845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method.
    Thorpe SJ; Fox BJ; Dolman CD; Thorpe R
    Biologicals; 2005 Jun; 33(2):111-6. PubMed ID: 15905100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-red blood cell antibodies, free light chains, and antiphospholipid antibodies in intravenous immunoglobulin preparations.
    Sakem B; Matozan K; Nydegger UE; Weigel G; Griesmacher A; Risch L
    Isr Med Assoc J; 2013 Oct; 15(10):617-21. PubMed ID: 24266088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D immunoglobulin-induced prolonged intravascular hemolysis and neutropenia.
    Alioglu B; Avci Z; Ozyurek E; Ozbek N
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):636-9. PubMed ID: 17805040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis upon intravenous immunoglobulin transfusion.
    Padmore RF
    Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic adverse effects of intravenous immunoglobulin: modeling predicts risk reduction with anti-A/B immunoaffinity chromatography and to a lesser extent with anti-A donor screening.
    Mallick R; Hubsch A; Barnes DG
    Transfusion; 2018 Dec; 58(12):2752-2756. PubMed ID: 30284263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of intravenous immunoglobulin.
    Misbah SA; Chapel HM
    Drug Saf; 1993 Oct; 9(4):254-62. PubMed ID: 8260119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolysis after treatment with intravenous immunoglobulin due to anti-A.
    Morgan S; Sorensen P; Vercellotti G; Zantek ND
    Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SSA antibodies are present in immunoglobulin preparations.
    van der Molen RG; Hamann D; Jacobs JF; van der Meer A; de Jong J; Kramer C; Strengers PF; van der Meer JW
    Transfusion; 2015 Apr; 55(4):832-7. PubMed ID: 25394209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.